This report was recently updated on April 24 2025 with the latest and most recent
market numbers
Global Electronic Drug Delivery Devices Market Size, Trends & Analysis - Forecasts to 2030 By Product (Smart Infusion Pumps (Infusion Systems) [Non-biologic Smart Infusion Systems and Biologic Smart Infusion Systems], Smart Metered Dose Inhalers (Inhalation Devices), Implantable Drug Delivery Devices [Biologic Implantable Drug Delivery Devices and Non-biologic Implantable Drug Delivery Devices], Smart Transdermal Patches (Transdermal Delivery Systems), and Others), By Application (Diabetes, Respiratory Diseases, Oncology, Cardiology, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global electronic drug delivery devices market is estimated to exhibit a CAGR of 8.4% from 2025 to 2030.
The primary factors propelling the market growth are the rising prevalence of chronic diseases like diabetes and respiratory disorders, and the increasing demand for home-based and self-administered drug therapies. Diabetes and respiratory disorders often require long-term, consistent medication regimens that benefit significantly from precise and controlled drug administration. Electronic drug delivery devices, including insulin pumps and smart inhalers, offer improved accuracy, dosage control, and adherence monitoring compared to traditional methods. For instance, diabetic patients rely on electronic insulin delivery systems for real-time glucose management and automated insulin dosing, reducing the risk of hypoglycemia and improving overall health outcomes. Similarly, patients with respiratory disorders benefit from electronic inhalers that ensure optimal drug deposition in the lungs while tracking usage data for physicians. The growing global burden of such chronic illnesses, combined with an increased focus on personalized and home-based care, is accelerating the adoption of advanced electronic delivery systems that enhance convenience, efficacy, and quality of life for patients.
Technological advancements in wearable and smart drug delivery systems, along with enhanced patient adherence through user-friendly electronic devices, are expected to support the market growth. Innovations such as Bluetooth-enabled insulin pumps, patch-based drug delivery systems, and sensor-integrated inhalers are transforming the way medications are administered and monitored. These smart devices offer real-time tracking, automated dosing, and integration with mobile apps or healthcare platforms, enabling personalized treatment plans and improved patient compliance. For example, wearable injectors for biologics provide a painless and convenient alternative to frequent hospital visits, especially for chronic disease patients. Moreover, the integration of artificial intelligence (AI) and Internet of Things (IoT) in these devices allows for predictive analytics, remote monitoring, and timely interventions by healthcare providers. As patients and healthcare systems increasingly seek solutions that combine convenience, precision, and connectivity, the demand for advanced, wearable electronic drug delivery systems continues to rise, reshaping the future of medication management and disease treatment.
Expansion of telehealth and remote patient monitoring solutions, coupled with the favorable regulatory support for digital health and connected devices, propels market growth. Regulatory bodies like the U.S. Food and Drug Administration (FDA) have introduced initiatives such as the Digital Health Center of Excellence (DHCoE) to foster innovation in digital health technologies, including Software as a Medical Device (SaMD) and connected drug delivery systems. The FDA's streamlined approval processes, exemplified by the clearance of devices like the BreatheSuite Metered-Dose Inhaler, have reduced barriers to market entry for innovative products. Additionally, the 21st Century Cures Act has modernized regulatory frameworks, facilitating faster development and deployment of digital health solutions. These regulatory advancements have increased healthcare providers' confidence in adopting electronic drug delivery devices, knowing they meet stringent safety and efficacy standards.
The integration of data analytics in drug delivery systems creates an opportunity to personalize treatment plans. Real-time monitoring and feedback mechanisms enable optimized dosage and timing, improving outcomes and offering better disease management for healthcare providers and patients. Additionally, the increasing use of biologics creates an opportunity for the development of electronic devices capable of delivering high-viscosity drugs. These devices can support subcutaneous delivery with precise control, opening new doors in autoimmune, oncology, and rare disease treatment. However, short battery life and reliance on consistent power sources may hinder market growth.
The implantable drug delivery devices segment is expected to hold the largest share of the market over the forecast period. Once implanted, these systems reduce the need for active patient participation, especially beneficial for elderly or cognitively impaired patients. This non-intrusive approach provides an opportunity to support vulnerable patient populations requiring long-term medication without daily management.
The smart metered dose inhalers (inhalation devices) segment is expected to be the fastest-growing segment in the market from 2025 to 2030. Smart inhalers track patient usage and send reminders, significantly improving medication adherence. This capability creates a key opportunity for better disease control and reduced exacerbations, which are often caused by missed doses or incorrect inhalation techniques.
The diabetes segment is expected to hold the largest share of the market over the forecast period. Many diabetes patients require multiple insulin doses per day. Electronic drug delivery devices offer automated, precise insulin administration, reducing the burden of frequent manual injections. This reliability creates a strong opportunity for long-term diabetes management solutions.
The oncology segment is anticipated to be the fastest-growing segment in the market from 2025 to 2030. Oncology is witnessing a surge in biologics and targeted therapies that require novel delivery methods. Electronic devices tailored to handle these sensitive drugs present a major opportunity to support advanced cancer treatments while preserving drug stability and efficacy.
North America is expected to be the largest region in the global market. The region has a significant burden of chronic conditions such as diabetes, cancer, and respiratory illnesses. This high prevalence creates a sustained demand for long-term drug delivery solutions, offering an opportunity for wide-scale adoption of advanced electronic drug delivery systems.
Asia Pacific is anticipated to witness rapid growth during the forecast period. Rising research and development investments and the establishment of local manufacturing units in countries like China, India, and Japan are contributing to innovation in drug delivery technologies. This focus on R&D and cost-effective production presents an opportunity to develop cutting-edge solutions that are tailored to the region’s unique market needs.
Medtronic plc, Insulet Corporation, Becton, Dickinson and Company (BD), Tandem Diabetes Care, Inc., Ypsomed AG, Novo Nordisk A/S, Sanofi S.A., Eli, Lilly and Company, AstraZeneca plc, and GlaxoSmithKline plc among others, are some of the key players in the global electronic drug delivery devices market.
Please note: This is not an exhaustive list of companies profiled in the report.
In January 2025, West Pharmaceutical Services introduced the Daikyo PLASCAP Ready-to-Use Validated (RUV) closures. These closures offer a straightforward, one-step method of vial sealing because they are made of metal-free polypropylene and have built-in stoppers.
In October 2024, Qnovia, Inc., a pharmaceutical corporation, gained FDA authorization for their inhaled medication delivery system, RespiRx (QN-1), a nicotine inhaler. The purpose of this inhaled nicotine replacement therapy (NRT) is to assist those who are attempting to stop smoking.
REPORT CONTENT
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL ELECTRONIC DRUG DELIVERY DEVICES MARKET, BY Product
4.1 Introduction
4.2 Electronic Drug Delivery Devices Market: Product Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Smart Infusion Pumps (Infusion Systems) [Non-biologic Smart Infusion Systems and Biologic Smart Infusion Systems]
4.4.1 Smart Infusion Pumps (Infusion Systems) [Non-biologic Smart Infusion Systems and Biologic Smart Infusion Systems] Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Smart Metered Dose Inhalers (Inhalation Devices)
4.5.1 Smart Metered Dose Inhalers (Inhalation Devices) Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Implantable Drug Delivery Devices [Biologic Implantable Drug Delivery Devices and Non-biologic Implantable Drug Delivery Devices]
4.6.1 Implantable Drug Delivery Devices [Biologic Implantable Drug Delivery Devices and Non-biologic Implantable Drug Delivery Devices] Market Estimates and Forecast, 2021-2029 (USD Million)
4.7 Smart Transdermal Patches (Transdermal Delivery Systems)
4.7.1 Smart Transdermal Patches (Transdermal Delivery Systems) Market Estimates and Forecast, 2021-2029 (USD Million)
4.8 Others
4.8.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL ELECTRONIC DRUG DELIVERY DEVICES MARKET, BY APPLICATION
5.1 Introduction
5.2 Electronic Drug Delivery Devices Market: Application Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Diabetes
5.4.1 Diabetes Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Respiratory Diseases
5.5.1 Respiratory Diseases Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Oncology
5.6.1 Oncology Market Estimates and Forecast, 2021-2029 (USD Million)
5.7 Cardiology
5.7.1 Cardiology Market Estimates and Forecast, 2021-2029 (USD Million)
5.8 Others
5.8.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL ELECTRONIC DRUG DELIVERY DEVICES MARKET, BY REGION
6.1 Introduction
6.2 North America Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.1 By Product
6.2.2 By Application
6.2.3 By Country
6.2.3.1 U.S. Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.1.1 By Product
6.2.3.1.2 By Application
6.2.3.2 Canada Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.2.1 By Product
6.2.3.2.2 By Application
6.2.3.3 Mexico Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.3.1 By Product
6.2.3.3.2 By Application
6.3 Europe Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.1 By Product
6.3.2 By Application
6.3.3 By Country
6.3.3.1 Germany Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.1.1 By Product
6.3.3.1.2 By Application
6.3.3.2 U.K. Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.2.1 By Product
6.3.3.2.2 By Application
6.3.3.3 France Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.3.1 By Product
6.3.3.3.2 By Application
6.3.3.4 Italy Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.4.1 By Product
6.3.3.4.2 By Application
6.3.3.5 Spain Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.5.1 By Product
6.3.3.5.2 By Application
6.3.3.6 Netherlands Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Product
6.3.3.6.2 By Application
6.3.3.7 Rest of Europe Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Product
6.3.3.6.2 By Application
6.4 Asia Pacific Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.1 By Product
6.4.2 By Application
6.4.3 By Country
6.4.3.1 China Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.1.1 By Product
6.4.3.1.2 By Application
6.4.3.2 Japan Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.2.1 By Product
6.4.3.2.2 By Application
6.4.3.3 India Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.3.1 By Product
6.4.3.3.2 By Application
6.4.3.4 South Korea Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.4.1 By Product
6.4.3.4.2 By Application
6.4.3.5 Singapore Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.5.1 By Product
6.4.3.5.2 By Application
6.4.3.6 Malaysia Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Product
6.4.3.6.2 By Application
6.4.3.7 Thailand Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Product
6.4.3.6.2 By Application
6.4.3.8 Indonesia Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.7.1 By Product
6.4.3.7.2 By Application
6.4.3.9 Vietnam Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.8.1 By Product
6.4.3.8.2 By Application
6.4.3.10 Taiwan Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.10.1 By Product
6.4.3.10.2 By Application
6.4.3.11 Rest of Asia Pacific Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.11.1 By Product
6.4.3.11.2 By Application
6.5 Middle East and Africa Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.1 By Product
6.5.2 By Application
6.5.3 By Country
6.5.3.1 Saudi Arabia Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.1.1 By Product
6.5.3.1.2 By Application
6.5.3.2 U.A.E. Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.2.1 By Product
6.5.3.2.2 By Application
6.5.3.3 Israel Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.3.1 By Product
6.5.3.3.2 By Application
6.5.3.4 South Africa Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.4.1 By Product
6.5.3.4.2 By Application
6.5.3.5 Rest of Middle East and Africa Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.5.1 By Product
6.5.3.5.2 By Application
6.6 Central and South America Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.1 By Product
6.6.2 By Application
6.6.3 By Country
6.6.3.1 Brazil Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.1.1 By Product
6.6.3.1.2 By Application
6.6.3.2 Argentina Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.2.1 By Product
6.6.3.2.2 By Application
6.6.3.3 Chile Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Product
6.6.3.3.2 By Application
6.6.3.3 Rest of Central and South America Electronic Drug Delivery Devices Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Product
6.6.3.3.2 By Application
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 Medtronic plc
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 Insulet Corporation
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 Becton, Dickinson and Company (BD)
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Tandem Diabetes Care, Inc.
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 Ypsomed AG
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 NOVO NORDISK A/S
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 Sanofi S.A.
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Eli, Lilly and Company
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 AstraZeneca plc
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 GlaxoSmithKline plc
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Type of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
2 Smart Infusion Pumps (Infusion Systems) [Non-biologic Smart Infusion Systems and Biologic Smart Infusion Systems] Market, By Region, 2021-2029 (USD Million)
3 Smart Metered Dose Inhalers (Inhalation Devices) Market, By Region, 2021-2029 (USD Million)
4 Implantable Drug Delivery Devices [Biologic Implantable Drug Delivery Devices and Non-biologic Implantable Drug Delivery Devices] Market, By Region, 2021-2029 (USD Million)
5 Smart Transdermal Patches (Transdermal Delivery Systems) Market, By Region, 2021-2029 (USD Million)
6 Others Market, By Region, 2021-2029 (USD Million)
7 Global Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
8 Diabetes Market, By Region, 2021-2029 (USD Million)
9 Respiratory Diseases Market, By Region, 2021-2029 (USD Million)
10 Oncology Market, By Region, 2021-2029 (USD Million)
11 Cardiology Market, By Region, 2021-2029 (USD Million)
12 Others Market, By Region, 2021-2029 (USD Million)
13 Regional Analysis, 2021-2029 (USD Million)
14 North America Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
15 North America Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
16 North America Electronic Drug Delivery Devices Market, By COUNTRY, 2021-2029 (USD Million)
17 U.S. Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
18 U.S. Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
19 Canada Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
20 Canada Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
21 Mexico Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
22 Mexico Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
23 Europe Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
24 Europe Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
25 EUROPE Electronic Drug Delivery Devices Market, By COUNTRY, 2021-2029 (USD Million)
26 Germany Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
27 Germany Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
28 U.K. Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
29 U.K. Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
30 France Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
31 France Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
32 Italy Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
33 Italy Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
34 Spain Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
35 Spain Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
36 Netherlands Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
37 Netherlands Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
38 Rest Of Europe Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
39 Rest Of Europe Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
40 Asia Pacific Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
41 Asia Pacific Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
42 ASIA PACIFIC Electronic Drug Delivery Devices Market, By COUNTRY, 2021-2029 (USD Million)
43 China Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
44 China Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
45 Japan Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
46 Japan Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
47 India Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
48 India Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
49 South Korea Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
50 South Korea Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
51 Singapore Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
52 Singapore Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
53 Thailand Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
54 Thailand Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
55 Malaysia Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
56 Malaysia Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
57 Indonesia Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
58 Indonesia Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
59 Vietnam Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
60 Vietnam Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
61 Taiwan Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
62 Taiwan Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
63 Rest of APAC Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
64 Rest of APAC Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
65 Middle East and Africa Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
66 Middle East and Africa Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
67 MIDDLE EAST & AFRICA Electronic Drug Delivery Devices Market, By COUNTRY, 2021-2029 (USD Million)
68 Saudi Arabia Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
69 Saudi Arabia Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
70 UAE Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
71 UAE Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
72 Israel Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
73 Israel Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
74 South Africa Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
75 South Africa Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
76 Rest Of Middle East and Africa Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
77 Rest Of Middle East and Africa Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
78 Central and South America Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
79 Central and South America Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
80 CENTRAL AND SOUTH AMERICA Electronic Drug Delivery Devices Market, By COUNTRY, 2021-2029 (USD Million)
81 Brazil Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
82 Brazil Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
83 Chile Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
84 Chile Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
85 Argentina Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
86 Argentina Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
87 Rest Of Central and South America Electronic Drug Delivery Devices Market, By Product, 2021-2029 (USD Million)
88 Rest Of Central and South America Electronic Drug Delivery Devices Market, By Application, 2021-2029 (USD Million)
89 Medtronic plc: Products & Services Offering
90 Insulet Corporation: Products & Services Offering
91 Becton, Dickinson and Company (BD): Products & Services Offering
92 Tandem Diabetes Care, Inc.: Products & Services Offering
93 Ypsomed AG: Products & Services Offering
94 NOVO NORDISK A/S: Products & Services Offering
95 Sanofi S.A.: Products & Services Offering
96 Eli, Lilly and Company: Products & Services Offering
97 AstraZeneca plc, Inc: Products & Services Offering
98 GlaxoSmithKline plc: Products & Services Offering
99 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Electronic Drug Delivery Devices Market Overview
2 Global Electronic Drug Delivery Devices Market Value From 2021-2029 (USD Million)
3 Global Electronic Drug Delivery Devices Market Share, By Product (2023)
4 Global Electronic Drug Delivery Devices Market Share, By Application (2023)
5 Global Electronic Drug Delivery Devices Market, By Region (Asia Pacific Market)
6 Technological Trends In Global Electronic Drug Delivery Devices Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Electronic Drug Delivery Devices Market
10 Impact Of Challenges On The Global Electronic Drug Delivery Devices Market
11 Porter’s Five Forces Analysis
12 Global Electronic Drug Delivery Devices Market: By Product Scope Key Takeaways
13 Global Electronic Drug Delivery Devices Market, By Product Segment: Revenue Growth Analysis
14 Smart Infusion Pumps (Infusion Systems) [Non-biologic Smart Infusion Systems and Biologic Smart Infusion Systems] Market, By Region, 2021-2029 (USD Million)
15 Smart Metered Dose Inhalers (Inhalation Devices) Market, By Region, 2021-2029 (USD Million)
16 Implantable Drug Delivery Devices [Biologic Implantable Drug Delivery Devices and Non-biologic Implantable Drug Delivery Devices] Market, By Region, 2021-2029 (USD Million)
17 Smart Transdermal Patches (Transdermal Delivery Systems) Market, By Region, 2021-2029 (USD Million)
18 Others Market, By Region, 2021-2029 (USD Million)
19 Global Electronic Drug Delivery Devices Market: By Application Scope Key Takeaways
20 Global Electronic Drug Delivery Devices Market, By Application Segment: Revenue Growth Analysis
21 Diabetes Market, By Region, 2021-2029 (USD Million)
22 Respiratory Diseases Market, By Region, 2021-2029 (USD Million)
23 Oncology Market, By Region, 2021-2029 (USD Million)
24 Cardiology Market, By Region, 2021-2029 (USD Million)
25 Others Market, By Region, 2021-2029 (USD Million)
26 Cloud Computing Market, By Region, 2021-2029 (USD Million)
27 Cybersecurity Market, By Region, 2021-2029 (USD Million)
28 Regional Segment: Revenue Growth Analysis
29 Global Electronic Drug Delivery Devices Market: Regional Analysis
30 North America Electronic Drug Delivery Devices Market Overview
31 North America Electronic Drug Delivery Devices Market, By Product
32 North America Electronic Drug Delivery Devices Market, By Application
33 North America Electronic Drug Delivery Devices Market, By Country
34 U.S. Electronic Drug Delivery Devices Market, By Product
35 U.S. Electronic Drug Delivery Devices Market, By Application
36 Canada Electronic Drug Delivery Devices Market, By Product
37 Canada Electronic Drug Delivery Devices Market, By Application
38 Mexico Electronic Drug Delivery Devices Market, By Product
39 Mexico Electronic Drug Delivery Devices Market, By Application
40 Four Quadrant Positioning Matrix
41 Company Market Share Analysis
42 Medtronic plc: Company Snapshot
43 Medtronic plc: SWOT Analysis
44 Medtronic plc: Geographic Presence
45 Insulet Corporation: Company Snapshot
46 Insulet Corporation: SWOT Analysis
47 Insulet Corporation: Geographic Presence
48 Becton, Dickinson and Company (BD): Company Snapshot
49 Becton, Dickinson and Company (BD): SWOT Analysis
50 Becton, Dickinson and Company (BD): Geographic Presence
51 Tandem Diabetes Care, Inc.: Company Snapshot
52 Tandem Diabetes Care, Inc.: Swot Analysis
53 Tandem Diabetes Care, Inc.: Geographic Presence
54 Ypsomed AG: Company Snapshot
55 Ypsomed AG: SWOT Analysis
56 Ypsomed AG: Geographic Presence
57 NOVO NORDISK A/S: Company Snapshot
58 NOVO NORDISK A/S: SWOT Analysis
59 NOVO NORDISK A/S: Geographic Presence
60 Sanofi S.A. : Company Snapshot
61 Sanofi S.A. : SWOT Analysis
62 Sanofi S.A. : Geographic Presence
63 Eli, Lilly and Company: Company Snapshot
64 Eli, Lilly and Company: SWOT Analysis
65 Eli, Lilly and Company: Geographic Presence
66 AstraZeneca plc, Inc.: Company Snapshot
67 AstraZeneca plc, Inc.: SWOT Analysis
68 AstraZeneca plc, Inc.: Geographic Presence
69 GlaxoSmithKline plc: Company Snapshot
70 GlaxoSmithKline plc: SWOT Analysis
71 GlaxoSmithKline plc: Geographic Presence
72 Other Companies: Company Snapshot
73 Other Companies: SWOT Analysis
74 Other Companies: Geographic Presence
The Global Electronic Drug Delivery Devices Market has been studied from the year 2019 till 2030. However, the CAGR provided in the report is from the year 2025 to 2030. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Electronic Drug Delivery Devices Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
![Global Electronic Drug Delivery Devices Market Size, Trends & Analysis - Forecasts to 2030 By Product (Smart Infusion Pumps (Infusion Systems) [Non-biologic Smart Infusion Systems and Biologic Smart Infusion Systems], Smart Metered Dose Inhalers (Inhalation Devices), Implantable Drug Delivery Devices [Biologic Implantable Drug Delivery Devices and Non-biologic Implantable Drug Delivery Devices], Smart Transdermal Patches (Transdermal Delivery Systems), and Others), By Application (Diabetes, Respiratory Diseases, Oncology, Cardiology, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis](https://www.globalmarketestimates.com/images/cat/Healthcare.png)
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
